C. Schöber

562 total citations
22 papers, 362 citations indexed

About

C. Schöber is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C. Schöber has authored 22 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C. Schöber's work include Colorectal Cancer Treatments and Studies (6 papers), Cancer Treatment and Pharmacology (6 papers) and Gastric Cancer Management and Outcomes (4 papers). C. Schöber is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Cancer Treatment and Pharmacology (6 papers) and Gastric Cancer Management and Outcomes (4 papers). C. Schöber collaborates with scholars based in Germany, United States and Austria. C. Schöber's co-authors include Hans‐Joachim Schmoll, Carsten Bokemeyer, Hans‐Joachim Wilke, Wolfram C. M. Dempke, M. Stahl, Thomas Müller, Wieland Voigt, Axel Grothey, A. Harstrick and H. Poliwoda and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Annals of Oncology.

In The Last Decade

C. Schöber

21 papers receiving 341 citations

Peers

C. Schöber

SURGE

ONCOL

PRM

NEURO

Mario Ghosn France

Sunmolu Beckley United States

Yolanda P. Trujillo United States

Hiroyuki Hiraki Japan

John W. McBroom United States

Duygu Gürel Türkiye

Hiroo Matsuura Japan

Claudio Graiff Italy

Anders Kjellman Sweden

Ethem Nezih Oral Türkiye

Mario Ghosn France

C. Schöber

150 ×0.8

SURGE

73 ×0.6

ONCOL

55 ×0.6

86 ×1.0

PRM

64 ×1.0

NEURO

Citations per year, relative to C. Schöber C. Schöber (= 1×) peers Mario Ghosn

Countries citing papers authored by C. Schöber

Since Specialization

Citations

This map shows the geographic impact of C. Schöber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Schöber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Schöber more than expected).

Fields of papers citing papers by C. Schöber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Schöber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Schöber. The network helps show where C. Schöber may publish in the future.

Co-authorship network of co-authors of C. Schöber

This figure shows the co-authorship network connecting the top 25 collaborators of C. Schöber. A scholar is included among the top collaborators of C. Schöber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Schöber. C. Schöber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Juen, Barbara, et al.. (2024). Defining vulnerabilities and enabling community engagement in epidemics preparedness: the CAVE model from Austria. European Journal of Public Health. 35(2). 276–281. 1 indexed citations

Jordan, Karin, Axel Grothey, Tanja Pelz, et al.. (2009). Impact of quality of life parameters and coping strategies on postchemotherapy nausea and vomiting. European Journal of Cancer Care. 19(5). 603–609. 5 indexed citations

Augstein, Petra, P Heinke, C. Schöber, & Eckhard Salzsieder. (2008). Impact of Cytokine- and FasL-induced Apoptosis in the β-Cell Line NIT-1. Hormone and Metabolic Research. 41(3). 207–212. 9 indexed citations

Grothey, Axel, Wieland Voigt, C. Schöber, et al.. (1999). The role of insulin-like growth factor I and its receptor in cell growth, transformation, apoptosis, and chemoresistance in solid tumors. Journal of Cancer Research and Clinical Oncology. 125(3-4). 166–173. 70 indexed citations

Schaefer, Birgit M., Christian Lorenz, Walter Back, et al.. (1998). AUTOLOGOUS TRANSPLANTATION OF UROTHELIUM INTO DEMUCOSALIZED GASTROINTESTINAL SEGMENTS: EVIDENCE FOR EPITHELIALIZATION AND DIFFERENTIATION OF IN VITRO EXPANDED AND TRANSPLANTED UROTHELIAL CELLS. The Journal of Urology. 159(1). 284–290. 28 indexed citations

Köhne, C.-H., Wolfgang Hiddemann, J. Schüller, et al.. (1995). Failure of orally administered dipyridamole to enhance the antineoplastic activity of fluorouracil in combination with leucovorin in patients with advanced colorectal cancer: a prospective randomized trial.. Journal of Clinical Oncology. 13(5). 1201–1208. 19 indexed citations

Bokemeyer, Carsten, A. Harstrick, C. Schöber, et al.. (1993). METASTATIC LEYDIG-CELL TUMORS OF THE TESTIS - REPORT OF 4 CASES AND REVIEW OF THE LITERATURE. International Journal of Oncology. 2(2). 241–4. 13 indexed citations

Schöber, C., Hans‐Joachim Schmoll, H. Poliwoda, et al.. (1992). Antitumour effect and symptomatic control with interferon α2b in patients with endocrine active tumours. European Journal of Cancer. 28(10). 1664–1666. 17 indexed citations

Schöber, C., et al.. (1992). A 3-day schedule of 5-fluorouracil and folinic acid in metastatic progressive colorectal cancer and its impact in terms of palliation.. PubMed. 19(2 Suppl 3). 136–40. 2 indexed citations

10.

Schöber, C., Carsten Bokemeyer, Michael Ståhl, et al.. (1992). The role of schedule dependency of 5-fluorouracil/leucovorin combinations in advanced colorectal cancer.. PubMed. 19(2 Suppl 3). 131–5. 9 indexed citations

11.

Stahl, M., H. Wilke, P. Preusser, et al.. (1991). Etoposide, Leukovorin and 5-Fluorouracil (ELF) in Advanced Gastric Carcinoma – Final Results of a Phase-II Study in Elderly Patients or Patients with Cardiac Risk. Oncology Research and Treatment. 14(4). 314–318. 5 indexed citations

12.

Harstrick, A., Hans‐Joachim Schmoll, Hans‐Joachim Wilke, et al.. (1991). Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma.. Journal of Clinical Oncology. 9(9). 1549–1555. 74 indexed citations

13.

Schuppert, Frank, C. Schöber, Jan von Overbeck, et al.. (1991). Therapie eines malignen sympathischen Paraganglioms des Zuckerkandl'schen Organs — ein Fallbericht. Journal of Molecular Medicine. 69(20). 937–942. 2 indexed citations

14.

Adamietz, Irenä us A., et al.. (1991). Palliative radiotherapy in plasma cell myeloma. Radiotherapy and Oncology. 20(2). 111–116. 32 indexed citations

15.

Rasse, M., et al.. (1991). [Intra- and extra-capsular condyle fractures in the growth period. Therapy, clinical course, complications].. PubMed. 46(1). 49–51. 4 indexed citations

16.

Wilke, H., P. Preusser, U. Fink, et al.. (1990). High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer — a phase II study in elderly patients or patients with cardiac risk. Investigational New Drugs. 8(1). 65–70. 43 indexed citations

17.

Harstrick, A., Hans‐Joachim Schmoll, Hans‐Joachim Wilke, et al.. (1990). High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: A phase II study. Annals of Oncology. 1(5). 375–376. 16 indexed citations

18.

Wilke, H., Hans‐Joachim Schmoll, P. Preusser, et al.. (1988). Folinic Acid (CF)/5-Fluorouracil (FUra) Combinations in Advanced Gastrointestinal Carcinomas. Advances in experimental medicine and biology. 244. 233–243. 1 indexed citations

19.

Wilke, H., Hans‐Joachim Schmoll, C. Schöber, et al.. (1988). Folinic acid (FA) plus 5-fluorouracil (FU) in progressive advanced colorectal cancer.. PubMed. 42(6). 373–80. 4 indexed citations

20.

Mohr, Magni, et al.. (1984). Zur Entstehung des Ernährungsverhaltens. Food / Nahrung. 28(3). 279–287.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact